Clinical Trials Browser

Phase 2 × Has results × Immunoglobulins, Intravenous × Clear all

NCT04438382 2026-06-02

Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis

Phase 2 Terminated

1 enrolled 1 chart

Other hematologic neoplasm

Hematologic Neoplasms

NCT01545518 2014-09-01

IVIG Treatment for Refractory Immune-Related Adult Epilepsy

Phase 2 Terminated

20 enrolled 3 charts

Drug Resistant Epilepsy, Autoimmune Diseases, Epilepsy, Epilepsies, Partial, Autoimmune Diseases of the Nervous System, Limbic Encephalitis